Research strategies of election campaign communication research

APF Canada Welcomes Vina Nadjibulla as Vice-President, Research & Strategy

Retrieved on: 
Tuesday, October 24, 2023

VANCOUVER, British Columbia, Oct. 24, 2023 (GLOBE NEWSWIRE) -- The Asia Pacific Foundation of Canada (APF Canada) is pleased to announce that Vina Nadjibulla will be joining APF Canada as Vice-President, Research & Strategy, effective November 7, 2023.

Key Points: 
  • VANCOUVER, British Columbia, Oct. 24, 2023 (GLOBE NEWSWIRE) -- The Asia Pacific Foundation of Canada (APF Canada) is pleased to announce that Vina Nadjibulla will be joining APF Canada as Vice-President, Research & Strategy, effective November 7, 2023.
  • She also has extensive experience working with national governments, non-profits, and philanthropic organizations in Canada, the U.S., Central Asia, and China.
  • “I am truly honoured and excited to be joining the Asia Pacific Foundation of Canada,” said Ms. Nadjibulla.
  • In her new role with APF Canada, she will be based at the Foundation’s headquarters in Vancouver, Canada.

Can a roof’s material cool the outside air and lower energy demand? An Argonne study says it can.

Retrieved on: 
Friday, September 29, 2023

Certain roofing materials can help cool the surrounding outside air and decrease the need for air conditioning (AC).

Key Points: 
  • Certain roofing materials can help cool the surrounding outside air and decrease the need for air conditioning (AC).
  • Cool roofs reduced AC energy consumption the most, followed by green roofs and solar panel roofs.
  • Energy demand was shown to be reduced by 16.6%, 14.0%, and 7.6%, when cool roofs, green roofs, and solar panel roofs are deployed, respectively.
  • Overall, the large-scale deployment of cool roofs showed the best potential for cooling effects and cooling energy saving.

First of Its Kind Argonne Dataset Shows Future Flooding Risk at Neighborhood Level

Retrieved on: 
Friday, September 29, 2023

Researchers at the U.S. Department of Energy’s (DOE) Argonne National Laboratory have developed a new dataset that estimates increased inland flood risk from climate change during the mid-21st century.

Key Points: 
  • Researchers at the U.S. Department of Energy’s (DOE) Argonne National Laboratory have developed a new dataset that estimates increased inland flood risk from climate change during the mid-21st century.
  • The first of its kind study performed six decade-long simulations using supercomputing resources at Argonne’s Laboratory Computing Resource Center and the Argonne Leadership Computing Facility, a DOE Office of Science user facility.
  • Agencies and industries are now considering climate change policies as extreme precipitation and flooding can pose significant risks to their infrastructures and networks.
  • Specifically, the researchers collaborated with AT&T and the New York Power Authority to help understand what kind of data they sought.

University of Phoenix College of Doctoral Studies Leadership Presents at 2023 American Psychological Association Convention

Retrieved on: 
Friday, August 18, 2023

Rodney Luster, Ph.D., chair, Center for Leadership Studies and Organizational Research (CLSOR) with the University of Phoenix College of Doctoral Studies, presented his research on addictive behavior and the chemical implications of a protein named FosB at the 2023 American Psychological Association Convention .

Key Points: 
  • Rodney Luster, Ph.D., chair, Center for Leadership Studies and Organizational Research (CLSOR) with the University of Phoenix College of Doctoral Studies, presented his research on addictive behavior and the chemical implications of a protein named FosB at the 2023 American Psychological Association Convention .
  • "In the dynamic landscape of psychology, the 2023 American Psychological Association Convention stands as a beacon of innovation and knowledge exchange for practitioners, and I am honored to be among this year’s presenters,” shares Luster.
  • Dr. Hinrich Eylers, vice provost of the College of Doctoral Studies at University of Phoenix, shared his support for Luster’s research contributions, stating, “Dr.
  • Luster earned his Ph.D. in Human Services with Capella University and completed a post-doctoral clinical internship with Johns Hopkins University.

Purpose Built Communities Announces Two New Vice Presidents to Leverage Data and Evidence to Strengthen Impact for Network Members and Communities

Retrieved on: 
Thursday, July 13, 2023

ATLANTA, July 12, 2023 /PRNewswire-PRWeb/ -- Purpose Built Communities welcomes two executives to its team – Karen Cramer, Vice President of Data, Technology and Impact, and Kevin Rafter, Vice President for Impact Strategy and Learning.These new hires will be key contributors to the leadership team as the national nonprofit supports communities across the country.

Key Points: 
  • Karen Cramer is Purpose Built's inaugural Vice President of Data, Technology and Impact.
  • Before joining Purpose Built, Karen served as the Chief Community Impact Officer at TechBridge, a national nonprofit whose mission is to alleviate poverty.
  • In this role, he will guide an evidence strategy for Purpose Built and its network that strengthens impact and ongoing learning.
  • "These two new leaders will be a game-changer for our organization," said Michelle Matthews, Executive Vice President at Purpose Built.

Akamis Bio Strengthens Leadership Team with Key Executive Appointments

Retrieved on: 
Thursday, July 6, 2023

as Chief Medical Officer (CMO), Peter Kosa, Ph.D. as Chief Business Officer (CBO), and Samantha Bailey-Bucktrout, Ph.D. as Senior Vice President, Head of Research.

Key Points: 
  • as Chief Medical Officer (CMO), Peter Kosa, Ph.D. as Chief Business Officer (CBO), and Samantha Bailey-Bucktrout, Ph.D. as Senior Vice President, Head of Research.
  • “As CMO, Oliver’s decades of experience in oncology drug development will be critical as we advance our lead program, NG-350A, toward clinical proof-of-concept studies.
  • Dr. Kosa has also held leadership positions at XOMA, Bayer Healthcare, and Connecticut Innovations.
  • She joined Akamis Bio from the Parker Institute for Cancer Immunotherapy in San Francisco where she was Senior Director of Research and Development.

Trends in Drug Benefit Design Report Released by Pharmaceutical Strategies Group

Retrieved on: 
Tuesday, June 13, 2023

DALLAS, June 13, 2023 /PRNewswire/ -- Pharmaceutical Strategies Group (PSG), an EPIC company, is pleased to announce the launch of its Trends in Drug Benefit Design Report. The report delivers innovative research on the latest trends in the traditional (non-specialty) drug benefit. Sponsored by Rx Savings Solutions, it outlines the complexities of designing and managing the drug benefit and the cost challenges faced by consumers and plan sponsors alike.

Key Points: 
  • DALLAS, June 13, 2023 /PRNewswire/ -- Pharmaceutical Strategies Group (PSG), an EPIC company, is pleased to announce the launch of its Trends in Drug Benefit Design Report.
  • The report delivers innovative research on the latest trends in the traditional (non-specialty) drug benefit.
  • Since the inception of this report, the drug benefit has become more intricate to design and manage.
  • This report helps benefit leaders identify trends and future possibilities so they can adjust as appropriate around these factors and more.

NEW RESEARCH REVEALS MOST CRITICAL FACTORS FOR ECZEMA PATIENTS IN CONSIDERING A CLINICAL TRIAL

Retrieved on: 
Thursday, May 11, 2023

NOVATO, Calif., May 11, 2023 /PRNewswire/ -- The National Eczema Association (NEA) today announced the first publication from its real-world research on clinical trial awareness and preferences among eczema patients and caregivers.

Key Points: 
  • NOVATO, Calif., May 11, 2023 /PRNewswire/ -- The National Eczema Association (NEA) today announced the first publication from its real-world research on clinical trial awareness and preferences among eczema patients and caregivers.
  • However, before eczema treatments can become available to patients, they must go through a lengthy and rigorous clinical trial process to make sure they are safe and effective.
  • NEA wanted to understand what goes into the clinical trial decision-making process, and conducted a survey to see what factors are most important to the eczema community when considering whether or not to participate in a clinical trial.
  • The survey asked participants to rate the importance of various factors when considering clinical trial participation.

Envestnet | PMC Launches ActivePassive ETFs, Combining Attributes of Active & Passive Management in One Cost-Effective Portfolio Solution

Retrieved on: 
Tuesday, May 9, 2023

BERWYN, Pa., May 9, 2023 /PRNewswire/ -- At a time when many advisors are seeking to create portfolio solutions featuring the benefits of both traditional active investments and low-cost passive investments, Envestnet | PMC has launched a series of ActivePassive Exchange-Traded Funds (ETFs) enabling financial advisors to access this combined strategy within cost-effective, tax-efficient, liquid, and transparent investment vehicles. These new ETFs will be featured in the ActivePassive PMC ETF Portfolios1.

Key Points: 
  • These new ETFs will be featured in the ActivePassive PMC ETF Portfolios1.
  • This launch supports Envestnet | PMC's ongoing research indicating that systematic factor-based strategies and skilled, traditional active strategies combined with passive investment vehicles may be a more efficient and cost-effective approach to returns generation.
  • The ETFs are available in the ActivePassive PMC ETF Portfolios, Envestnet | PMC's ActivePassive multi-asset model portfolios, and have been offered to implement the views of the models' portfolio managers in a tax-efficient way with no additional management fee.
  • Greg Classen, CFA, Principal Director of Portfolio Management at Envestnet | PMC, and Tim Murphy, Director of Portfolio Management at PMC, have led the management of the ActivePassive PMC Portfolios since 2014, producing attractive results relative to benchmarks and peers.

Dr. Rodney Luster and Dr. Talee Vang to Deliver Keynote Speech for Day Two of University of Phoenix Inclusive Leadership Summit and Career Fair

Retrieved on: 
Monday, April 24, 2023

University of Phoenix is pleased to announce Dr. Rodney Luster and Dr. Talee Vang as the keynote speakers for the second day of the University’s annual Inclusive Leadership Summit and Career Fair, May 2-4, 2023 .

Key Points: 
  • University of Phoenix is pleased to announce Dr. Rodney Luster and Dr. Talee Vang as the keynote speakers for the second day of the University’s annual Inclusive Leadership Summit and Career Fair, May 2-4, 2023 .
  • Throughout this session, there will be opportunities to discuss how these challenges disproportionately impact workplaces, schools, the healthcare system, and other social settings.
  • Participants will leave with practical resources to put inclusive leadership skills into practice and a greater understanding of potential impact.
  • Participants will engage in facilitated conversations about workforce trends and learn the skills necessary to become effective inclusive leaders in the workplace.